F-star appoints Dr Louis Kayitalire as Chief Medical Officer

80

CAMBRIDGE, England–(BUSINESS WIRE)–F-star, a clinical-stage biopharmaceutical company delivering tetravalent bispecific antibodies for a paradigm-shift in cancer therapy, today announces the appointment of Louis Kayitalire, MD, as Chief Medical Officer (CMO), which will be effective on 17 June 2019. F-star believes this newly created management position will be crucial to F-star’s transition to a wholly-owned portfolio strategy as it expands its clinical operation capabilities and accelerates…..

 

http://www.businesswire.com/news/home/20190610005311/en/F-star-appoints-Dr-Louis-Kayitalire-Chief-Medical